Yamashita, H.;                     Nakayama, K.;                     Kanno, K.;                     Ishibashi, T.;                     Ishikawa, M.;                     Iida, K.;                     Razia, S.;                     Kiyono, T.;                     Kyo, S.    
        Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer. Cancers 2024, 16, 1999.
    https://doi.org/10.3390/cancers16111999
    AMA Style
    
                                Yamashita H,                                 Nakayama K,                                 Kanno K,                                 Ishibashi T,                                 Ishikawa M,                                 Iida K,                                 Razia S,                                 Kiyono T,                                 Kyo S.        
                Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer. Cancers. 2024; 16(11):1999.
        https://doi.org/10.3390/cancers16111999
    
    Chicago/Turabian Style
    
                                Yamashita, Hitomi,                                 Kentaro Nakayama,                                 Kosuke Kanno,                                 Tomoka Ishibashi,                                 Masako Ishikawa,                                 Kouji Iida,                                 Sultana Razia,                                 Tohru Kiyono,                                 and Satoru Kyo.        
                2024. "Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer" Cancers 16, no. 11: 1999.
        https://doi.org/10.3390/cancers16111999
    
    APA Style
    
                                Yamashita, H.,                                 Nakayama, K.,                                 Kanno, K.,                                 Ishibashi, T.,                                 Ishikawa, M.,                                 Iida, K.,                                 Razia, S.,                                 Kiyono, T.,                                 & Kyo, S.        
        
        (2024). Evaluation of ARID1A as a Potential Biomarker for Predicting Response to Immune Checkpoint Inhibitors in Patients with Endometrial Cancer. Cancers, 16(11), 1999.
        https://doi.org/10.3390/cancers16111999